Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05949593 |
|---|---|
| Brief Title: | Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy (PHOENIX) |
| First Submitted : | July 10, 2023 |
| First Submitted that Met QC Criteria : | July 10, 2023 |
| First Posted : | July 18, 2023 |
| Last Update Submitted that Met QC Criteria : | March 17, 2024 |
| Last Update Posted : | March 19, 2024 |